BiomX (PHGE) Fundamental Analysis: Revenue, Earnings & Valuation

2.63 / 10

Underperform

Fundamental evaluation scores 2.6/10, classifying BiomX as underperforming. Strengths include solid accounts‑receivable turnover and interest coverage, yet income‑tax‑to‑profit and fixed‑asset turnover are weak. Overall metrics point to defensive positioning and limited growth potential.

Analysis Checks(6/10)

Revenue-MV

Value-0.08

Score3/3

Weight47.84%

1M Return8.83%

Total operating revenue (YoY growth rate %)

Value134.75

Score2/3

Weight2.54%

1M Return0.58%

Inventory turnover ratio

Value106.57

Score3/3

Weight-2.72%

1M Return-0.67%

Accounts receivable turnover ratio

Value23.61

Score2/3

Weight-2.69%

1M Return-0.65%

PB-ROE

Value7.15

Score1/3

Weight25.37%

1M Return5.22%

Income tax / Total profit (%)

Value-0.02

Score1/3

Weight-2.46%

1M Return-0.59%

Fixed assets turnover ratio

Value9771.06

Score1/3

Weight-5.04%

1M Return-1.28%

Interest coverage ratio (EBIT / Interest expense) (%)

Value34.91

Score2/3

Weight-3.04%

1M Return-0.73%

Cost of sales ratio (%)

Value57.03

Score2/3

Weight-2.98%

1M Return-0.74%

Asset-MV

Value-0.55

Score1/3

Weight43.18%

1M Return7.28%

Is PHGE undervalued or overvalued?

PHGE scores 2.63/10 on fundamentals and holds a Premium valuation at present. Backed by its -316.90% ROE, 0.00% net margin, -0.84 P/E ratio, -23.22 P/B ratio, and 12.53% earnings growth, these metrics solidify its Underperform investment rating.